# Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

> **NCT00844402** · PHASE3 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 40 (actual)

## Conditions studied

- Primary Biliary Cirrhosis
- Hypercholesterolemia

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00844402
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00844402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00844402, "Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00844402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*